Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Lee

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|September 20, 2018
Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitorsJian-Kang Jiang, Xiuli Huang, Khalida Shamim, et al.
JCI Insight|March 11, 2021
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressivaEleanor Williams, Jana Bagarova, Georgina Kerr, et al.
Science Translational Medicine|November 25, 2016
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossificationDevaveena Dey, Jana Bagarova, Sarah J Hatsell, et al.
Cancers|February 13, 2026
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001Elena Gabriela Chiorean, Sheela R Damle, David B Zhen, et al.
Structural Heart : the Journal of the Heart Team|March 26, 2026
Automated Referral Prompts Reveal Lack of Equitable Access to Care in Patients With Aortic StenosisSophie Offen, Sarah Johns, Terra Boone, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2018
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary HypertensionIvana Nikolic, Lai-Ming Yung, Peiran Yang, et al.
Nature Cancer|February 5, 2022
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunityShelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug DesignKatherine L Lee, Catherine M Ambler, David R Anderson, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|September 20, 2018
Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitorsJian-Kang Jiang, Xiuli Huang, Khalida Shamim, et al.
JCI Insight|March 11, 2021
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressivaEleanor Williams, Jana Bagarova, Georgina Kerr, et al.
Science Translational Medicine|November 25, 2016
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossificationDevaveena Dey, Jana Bagarova, Sarah J Hatsell, et al.
Cancers|February 13, 2026
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001Elena Gabriela Chiorean, Sheela R Damle, David B Zhen, et al.
Structural Heart : the Journal of the Heart Team|March 26, 2026
Automated Referral Prompts Reveal Lack of Equitable Access to Care in Patients With Aortic StenosisSophie Offen, Sarah Johns, Terra Boone, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2018
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary HypertensionIvana Nikolic, Lai-Ming Yung, Peiran Yang, et al.
Nature Cancer|February 5, 2022
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunityShelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug DesignKatherine L Lee, Catherine M Ambler, David R Anderson, et al.
Pageof 5